CATALYST PHARMACEUTICALS, INC.

CPRX · Nasdaq · SIC 2834: Pharmaceutical Preparations
329
SEC Filings

Business Summary

Overview FIRDAPSE. The outcome of patent litigation with Paragraph IV challengers is always uncertain and there can be no assurance as to whether we will prevail in this litigation. Other Litigation From time to time we may become involved in legal proceedings arising in the ordinary course of business. Other than as set forth above, we believe that there is no litigation pending at this time that could have, individually or in the aggregate, a material adverse effect on our results of operation...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCPRXdiscussed_in_filing Cybersecurity
topic_mentionCPRXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001193125-26-071525EDGAR94K words
2025-02-262024-12-310000950170-25-027714EDGAR—
2024-02-282023-12-310001193125-24-050908EDGAR—
2023-03-152022-12-310001193125-23-071299EDGAR—
2022-03-162021-12-310001193125-22-077228EDGAR—
2021-03-152020-12-310001193125-21-081545EDGAR—
2020-03-162019-12-310001193125-20-075048EDGAR—
2019-03-182018-12-310001193125-19-078253EDGAR—
2018-03-142017-12-310001193125-18-082292EDGAR—
2017-03-152016-12-310001193125-17-083667EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266854EDGAR38K words
2025-08-062025-06-300000950170-25-104000EDGAR—
2025-05-072025-03-310000950170-25-065652EDGAR—
2024-11-062024-09-300000950170-24-122282EDGAR—
2024-08-072024-06-300000950170-24-092745EDGAR—
2024-05-082024-03-310001193125-24-134195EDGAR—
2023-11-082023-09-300001193125-23-273506EDGAR—
2023-08-092023-06-300001193125-23-207344EDGAR—
2023-05-102023-03-310001193125-23-140701EDGAR—
2022-11-092022-09-300001193125-22-281202EDGAR—
2022-08-092022-06-300001193125-22-216148EDGAR—
2022-05-102022-03-310001193125-22-146274EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-180001193125-26-114306EDGAR0K words
2026-02-250001193125-26-071702EDGAR—
2026-01-120001193125-26-009822EDGAR—
2025-11-050001193125-25-267038EDGAR—
2025-10-010001193125-25-226837EDGAR—
2025-08-250001193125-25-187733EDGAR—
2025-08-070001193125-25-175477EDGAR—
2025-08-060001193125-25-174540EDGAR—
2025-08-040001193125-25-172653EDGAR—
2025-06-020001193125-25-133348EDGAR—

329 total filings indexed. 297 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001369568
TickerCPRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 74a54bc9bb72588eda279460776fb9dbbcc1da61a5b32f5c4809db364685a129
parent: 930347567765aa01f88af6d60be31b28af9971651ff37205d51224fd4b4475d8
content hash: d0a96a21daa1cf7b4c4af829b794817fdce5a53b39f02d4ed6ab30eaf025354b
signed: 2026-04-13T04:44:28.006Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf